Regencell Bioscience Holdings Limited RGC
Regular-session close
Pre-market · Nov 17, 5:20 AM ET
- YTD
- -77.52%
- 1 year
- -63.50%
- Market cap
- 2.34B
- EPS (ttm)
- -0.02
- Shares out
- 495.88M
- YTD return
- -77.52%
- 1-year return
- -63.50%
- 50-day average
- 6.79
- 200-day average
- 15.98
- Volume
- 92.61K
- Avg volume
- 239.97K
- Open
- 4.86
- Previous close
- 4.94
- Day's range
- 4.60 – 4.86
- 52-week range
- 4.51 – 69.00
- Beta
- 1.71
5D -0.78 (-14.18%)
Key statistics
- Enterprise value
- 2.44B
- Price / book
- 174.81
- Free cash flow
- -2.99M
- Total cash
- 14.19M
- Total debt
- 295.81K
- Return on equity
- -128.53%
- Short % of float
- 0.63%
Fundamental scorecard
3 of 25 checks passed on RGC’s reported financials
3of 25 checks passed
- Value 0 of 5
- Growth 0 of 5
- Profitability 0 of 5
- Financial health 3 of 5
- Dividend 0 of 5
Statements to Jun 30, 2026.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 28, 2026 | Jun 30, 2026 | — | -0.0129 | — | — |
| Jun 15, 2026 | Dec 31, 2025 | — | -0.0107 | — | — |
| Nov 18, 2025 | Jun 30, 2025 | — | -0.0035 | — | — |
| Jun 26, 2025 | Dec 29, 2024 | — | -0.0037 | — | — |
| Oct 25, 2024 | Jun 30, 2024 | — | -0.0045 | — | — |
| Jan 26, 2024 | Dec 30, 2023 | — | 0.00 | — | — |
About Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Limited focuses on the research, development, and commercialization of Traditional Chinese Medicine (TCM) in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, TCM brain theory, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Hong Kong
- Website
- regencellbioscience.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on RGC — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Geode Capital Management, LLC | 0.09% | 423,370 | 2.00M | Sep 29, 2026 |
| Alyeska Investment Group, L.p. | 0.08% | 416,261 | 1.96M | Jun 29, 2026 |
| Legal & General Group PLC | 0.03% | 128,000 | 604.16K | Jun 29, 2026 |
| Cerity Partners LLC | 0.03% | 128,706 | 607.49K | Sep 29, 2026 |
| Jane Street Group, LLC | 0.02% | 81,697 | 385.61K | Sep 29, 2026 |
| Xtx Topco Ltd | 0.01% | 60,061 | 283.49K | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 0.06% | 301,859 | 1.42M | Sep 29, 2026 |
| Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF | 0.02% | 121,511 | 573.53K | Sep 29, 2026 |
| John Hancock Variable Insurance Trust-Total Stock Market Index Trust | 0.00% | 7,602 | 35.88K | Jun 29, 2026 |
| Invesco Exch-Trd Fd. TRT II-Invesco S&P Emerging Markets Momentum ETF | 0.00% | 478 | 2.26K | Aug 30, 2026 |
| SPDR INDEX SHARES FUNDS-State Street SPDR S&P China ETF | 0.00% | 4,051 | 19.12K | Sep 29, 2026 |
